Dechra Pharmaceuticals PLC
Dechra Pharmaceuticals PLC (DPHAY) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · DPHAY · as of Jun 8, 2026
Key Statistics
Explore Dechra Pharmaceuticals PLC Data
dphay stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
dphay competitorsDPHAY
ABCZF
ANHGY
ASPHF
CAKFY
GALNFStock Performance
Full HistoryAbout Dechra Pharmaceuticals PLC
Dechra Pharmaceuticals PLC (DPHAY) is dedicated to the development, manufacturing, regulatory approval, marketing, and sale of veterinary medications and related goods specifically for animal health p…
what is dechra pharmaceuticals plc · dphay stock overview · dechra pharmaceuticals plc company profile · who is dechra pharmaceuticals plc ceo · dphay OTC · dechra pharmaceuticals plc headquarters · dechra pharmaceuticals plc business segments
About Stock Overview & Key Data
Dechra Pharmaceuticals PLC (DPHAY) is a Healthcare company in the Drug Manufacturers - General industry, listed on OTC since Feb 26, 2018. As of the latest trading session, DPHAY stock price is $98.00, with a market capitalization of $5.6B. The stock has returned +31.92% over the past 12 months and +3.95% year-to-date.
In fiscal year 2023, Dechra Pharmaceuticals PLC reported revenue of $761.5M. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Dechra Pharmaceuticals PLC (DPHAY) stock price is $98.00. The stock is traded on OTC under the ticker symbol DPHAY. The 52-week range is $61.61 – $98.00.